Anavex Life Sciences Corp (AVXL)

[Investor2014]

Regarding trial design confusion,

this Alzforum link

In the comment section, Kristina Capiak clears up whether the trial protocol was changed during the part A and B 5 + 52 week period.

Comments on this content

User Profile Image Kristina Capiak
Anavex Life Science Corp.
Posted: 03 Mar 2016
The protocol or trial design or entry criteria were never changed after trial approval by the ethics committee, with the exception of extending Part B from 26 to 52 weeks. The first input into clinicaltrials.gov was performed by a new CRO member, who was not familiar with the specific entry templates into clinicaltrials.gov, hence this had to be corrected to accurately reflect the particulars of the trial.

VIEW ALL COMMENTS BY KRISTINA CAPIAK